Pashupati Cotspin Limited processes raw cotton through ginning, spinning, and delineating processes to produce cotton bales, yarn, and seeds. It has set up a sizable manufacturing facility in Gujarat, with 25,536 spindles and 56 ginning units, strategically located near key cotton-growing regions.

The company's strategic move into the pharmaceutical sector signals diversified growth and adapts to new industry dynamics. This diversification aligns the company with broader market opportunities.

Pashupati Cotspin's public listing on NSE Emerge provided crucial capital for expansion and operational scale, enhancing its footprint in the textile industry.

The company benefits significantly from government initiatives supporting textile industry growth, especially in crafting more integrated operations.